Detalhe da pesquisa
1.
Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization.
Eur J Neurol
; 30(9): 2781-2792, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310391
2.
Molecular basis of dopamine replacement therapy and its side effects in Parkinson's disease.
Cell Tissue Res
; 373(1): 111-135, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29516217
3.
Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.
Mov Disord
; 33(12): 1878-1886, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30444952
4.
Gene expression analyses identify Narp contribution in the development of L-DOPA-induced dyskinesia.
J Neurosci
; 35(1): 96-111, 2015 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25568106
5.
RAD51 haploinsufficiency causes congenital mirror movements in humans.
Am J Hum Genet
; 90(2): 301-7, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22305526
6.
Development and validation of a rapid and simple LC-MS/MS method for quantification of vemurafenib in human plasma: application to a human pharmacokinetic study.
Ther Drug Monit
; 37(1): 132-6, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24977381
7.
The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
Acta Neuropathol
; 128(5): 705-22, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859968
8.
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
J Neurol Neurosurg Psychiatry
; 84(6): 666-73, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408064
9.
The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Ann Neurol
; 69(1): 111-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21280081
10.
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.
Orphanet J Rare Dis
; 12(1): 160, 2017 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969699
11.
A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia.
Neurology
; 86(18): 1729-35, 2016 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27053715
12.
Correction: Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
PLoS One
; 11(9): e0162937, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27606465
13.
Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial.
PLoS One
; 11(7): e0158235, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27403743
14.
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
Neurosci Lett
; 583: 76-80, 2014 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25233866
15.
Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
Parkinsonism Relat Disord
; 20(2): 170-5, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24216088